Robert Nelsen Karuna Therapeutics, Inc. (KRTX) insider trading activity

KRTX Quotes by TradingView

Robert Nelsen is Director of Karuna Therapeutics, Inc.. Currently has a direct ownership of 5,269 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Apr 13, 2021, when has been sold 1,756 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.27K
0% 3M change
0% 12M change
Total Value Held $0

ROBERT NELSEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 13 2021
BUY
Other acquisition or disposition
-
1,756 Added 25.0%
5,269 Common Stock
Jan 08 2021
BUY
Other acquisition or disposition
-
1,756 Added 33.33%
3,513 Common Stock
Nov 12 2020
BUY
Other acquisition or disposition
-
1,757 Added 50.0%
1,757 Common Stock

Also insider at

BEAM
Beam Therapeutics Inc. Healthcare
Director
SANA
Sana Biotechnology, Inc. Healthcare
VIR
Vir Biotechnology, Inc. Healthcare
Director
DNLI
Denali Therapeutics Inc. Healthcare
Director
LYEL
Lyell Immunopharma, Inc. Healthcare
PRME
Prime Medicine, Inc.
Director
RN

Robert Nelsen

Director
Chicago, IL

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRTX